학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 86건 | 목록 1~20
Academic Journal
Tounekti O; Health Canada, Ottawa, Ontario, Canada.; Shubow S; US FDA, Silver Spring, Maryland, United States.; Wassmer S; Health Canada, Ottawa, Ontario, Canada.; Van Tuyl A; AstraZeneca, Gaithersburg, Maryland, United States.; Yang L; BioMarin, Novato, California, United States.; Gong B; US FDA, Jefferson, Arkansas, United States.; Abhari MR; Novartis, Cambridge, Massachusetts, United States.; Kalina W; Pfizer, Pearl River, New York, United States.; Myler H; Takeda, Yardley, Pennsylvania, United States.; DelCarpini J; Moderna, Cambridge, Massachusetts, United States.; Escobar D; Navigate, Carlsbad, California, United States.; Fiscella M; REGENXBIO, Rockville, Maryland, United States.; Gorovits B; Regeneron, Tarrytown, New York, United States.; Gupta S; AbbVie, Irvine, California, United States.; Irvin SC; Regeneron, Tarrytown, New York, United States.; Irwin C; Health Canada, Ottawa, Ontario, Canada.; Jankowski W; US FDA, Silver Spring, Maryland, United States.; Jawa V; Bristol Myers Squibb, Lawrenceville, New Jersey, United States.; Karauzum H; Pfizer, Pearl River, New York, United States.; Kerridge C; UK MHRA, London, United Kingdom.; Lu Y; Sangamo, Richmond, California, United States.; Mayer C; Austria AGES/ EU EMA, Vienna, Austria.; McGregor J; WRIB, Toronto, Ontario, Canada.; Melton A; AstraZeneca, Gaithersburg, Maryland, United States.; Murphy R; Sanofi, Swiftwater, Pennsylvania, United States.; Nanra J; GSK, Cambridge, Massachusetts, United States.; Nowocin A; UK MHRA, London, United Kingdom.; Partridge MA; Regeneron, Tarrytown, New York, United States.; Prior S; UK MHRA, London, United Kingdom.; Sauna Z; US FDA, Silver Spring, Maryland, United States.; Scott B; Health Canada, Ottawa, Ontario, Canada.; Seitzer J; Intellia, Windham, New Hampshire, United States.; Stern M; Bristol Myers Squibb, Lawrenceville, New Jersey, United States.; Sugimoto H; Takeda, Cambridge, Massachusetts, United States.; Taylor M; Moderna, Cambridge, Massachusetts, United States.; Wong A; Health Canada, Ottawa, Ontario, Canada.; Xiao W; US FDA, Silver Spring, Maryland, United States.; Xu Y; Intellia, Cambridge, Massachusetts, United States.; Yang TY; J&J Innovative Medicine, Spring House, Pennsylvania, United States.; Yuill D; AstraZeneca, Cambridge, United Kingdom.; Kubiak RJ; Third Arc Bio, Lower Gwynedd, Pennsylvania, United States.; Thway T; Eisai, Nutley, New Jersey, United States.; Gunn G; GSK, Collegeville, Pennsylvania, United States.; Pelto R; Alexion, Higganum, Connecticut, United States.; Sumner G; Regeneron, Tarrytown, New York, United States.; Baltrukonis D; Pfizer, Groton, Connecticut, United States.; Dholakiya SL; Bristol Myers Squibb, Lawrenceville, New Jersey, United States.; Dogmanits S; GSK, Collegeville, Pennsylvania, United States.; Garofolo F; BRI Frontage, Vancouver, British Columbia, Canada.; Jadhav M; Novartis, Cambridge, Massachusetts, United States.; Kramer D; Sanofi, Frankfurt am Main, Germany.; Meyer E; GSK, Collegeville, Pennsylvania, United States.; Mohapatra S; Stoke, Bedford, Massachusetts, United States.; Mozaffari R; GSK, Collegeville, Pennsylvania, United States.; Peng K; Genentech, South San Francisco, California, United States.; Pine S; Sanofi, Zwijnaarde, Belgium.; Poetzl J; Sandoz, Holzkirchen, Germany.; Rasamoelisolo M; Teva, West Chester, Pennsylvania, United States.; Shao W; BioMarin, Novato, California, United States.; Staack RF; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany.; Swanson S; Genentech, South San Francisco, California, United States.; Taqui A; Gilead, Foster City, California, United States.; Vauleon S; F. Hoffmann-La Roche, Basel, Switzerland.; Wang Y; Lilly, Indianapolis, Indiana, United States.; Wen Y; Lilly, Indianapolis, Indiana, United States.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101512484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-6199 (Electronic) Linking ISSN: 17576180 NLM ISO Abbreviation: Bioanalysis Subsets: MEDLINE
Academic Journal
Cohen-Barak O; Teva Pharmaceutical Industries, Netanya, Israel.; Radivojevic A; IntiGrowth LLC, New York, NY, USA.; Jones A; Cognigen Corporation, a Simulations Plus company, Buffalo, NY, USA.; Fiedler-Kelly J; Cognigen Corporation, a Simulations Plus company, Buffalo, NY, USA.; Gillespie M; Teva Pharmaceutical Industries, West Chester, PA, USA.; Brennan M; Teva Pharmaceutical Industries, West Chester, PA, USA.; Gutman D; Teva Pharmaceutical Industries, Netanya, Israel.; Rasamoelisolo M; Teva Pharmaceutical Industries, West Chester, PA, USA.; Hallak H; Teva Pharmaceutical Industries, Netanya, Israel.; Loupe P; Teva Pharmaceutical Industries, West Chester, PA, USA.; Kessler Y; Teva Pharmaceutical Industries, Netanya, Israel.; Ning X; Teva Pharmaceutical Industries, West Chester, PA, USA.; Levi M; Teva Pharmaceutical Industries, West Chester, PA, USA.; Ahn AH; Teva Pharmaceutical Industries, West Chester, PA, USA.; Rabinovich-Guilatt L; Teva Pharmaceutical Industries, Netanya, Israel.
Publisher: Sage Country of Publication: England NLM ID: 8200710 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2982 (Electronic) Linking ISSN: 03331024 NLM ISO Abbreviation: Cephalalgia Subsets: MEDLINE
Academic Journal
Pan L; Takeda, Cambridge, MA, USA.; Mora J; Bristol Myers Squibb, Lawrenceville, NJ, USA.; Walravens K; GlaxoSmithKline, Rixensart, Belgium.; Wagner L; US FDA, Silver Spring, MD, USA.; Hopper S; UK MHRA, London, UK.; Loo L; Vertex, Boston, MA, USA.; Bettoun D; Larimar, Bala-Cynwyd, PA, USA.; Bond S; Alnylam, Cambridge, MA, USA.; Dessy F; GlaxoSmithKline, Rixensart, Belgium.; Downing S; Takeda, Cambridge, MA, USA.; Garofolo F; BRI Frontage, Vancouver, BC, Canada.; Gupta S; BioMarin, Novato, CA, USA.; Henderson N; AstraZeneca, Gothenburg, Sweden.; Irwin C; Health Canada, Ottawa, ON, Canada.; Ishii-Watabe A; Japan MHLW, Tokyo, Japan.; Kar S; WRIB, Montreal, QC, Canada.; Jawa V; Bristol Myers Squibb, Lawrenceville, NJ, USA.; Joseph J; Health Canada, Ottawa, ON, Canada.; Malvaux L; GlaxoSmithKline, Rixensart, Belgium.; Marshall JC; Moderna, Mystic, CT, USA.; McDevitt J; Bristol Myers Squibb, Lawrenceville, NJ, USA.; Mohapatra S; Stoke, Cambridge, MA, USA.; Seitzer J; Intellia, Cambridge, MA, USA.; Smith J; Pfizer, Groton, CT, USA.; Solstad T; Norway NoMA, Oslo, Norway.; Sugimoto H; Takeda, Cambridge, MA, USA.; Tounekti O; Health Canada, Ottawa, ON, Canada.; Wu B; Janssen R&D, Spring House, PA, USA.; Wu Y; AstraZeneca, Gaithersburg, MD, USA.; Xu Y; Intellia, Cambridge, MA, USA.; Xu J; US FDA, Jefferson, AR, USA.; Yamamoto T; Japan MHLW, Tokyo, Japan.; Yang L; REGENXBIO, Rockville, MD, USA.; Torri A; Regeneron, Tarrytown, NY, USA.; Kirshner S; US FDA, Silver Spring, MD, USA.; Maxfield K; US FDA, Silver Spring, MD, USA.; Vasconcelos JP; US FDA, Silver Spring, MD, USA.; Abhari MR; US FDA, Silver Spring, MD, USA.; Verthelyi D; US FDA, Silver Spring, MD, USA.; Brodsky E; US FDA, Silver Spring, MD, USA.; Carrasco-Triguero M; Sangamo, Brisbane, CA, USA.; Kamerud J; Pfizer, Groton, CT, USA.; Andisik M; Regeneron, Tarrytown, NY, USA.; Baltrukonis D; Pfizer, Groton, CT, USA.; Bivi N; Lilly, Indianapolis, IN, USA.; Cludts I; UK MHRA, London, UK.; Coble K; Boehringer Ingelheim, Danbury, CT, USA.; Gorovits B; Sana Bio, Cambridge, MA, USA.; Gunn GR; GSK, Collegeville, PA, USA.; Gupta S; AbbVie, Irvine, CA, USA.; Millner AH; Novo Nordisk, Maaloev, Denmark.; Joyce A; Pfizer, Groton, CT, USA.; Kubiak RJ; AstraZeneca, Gaithersburg, MD, USA.; Kumar S; EMD Serono, Boston, MA, USA.; Liao K; Merck, West Point, PA, USA.; Manangeeswaran M; US FDA, Silver Spring, MD, USA.; Partridge M; Regeneron, Tarrytown, NY, USA.; Pine S; Sanofi, Ghent, Belgium.; Poetzl J; Sandoz, Oberhaching, Germany.; Rajadhyaksha M; Alexion, New Haven, CT, USA.; Rasamoelisolo M; Teva, West Chester, PA, USA.; Richards S; Sanofi, Framingham, MA, USA.; Song Y; Genentech, South San Francisco, CA, USA.; Swanson S; Genentech, South San Francisco, CA, USA.; Thacker S; US FDA, Silver Spring, MD, USA.; Wadhwa M; UK MHRA, London, UK.; Wolf A; Amgen, Munich, Germany.; Zhang L; Health Canada, Ottawa, ON, Canada.; Zhou L; US FDA, Silver Spring, MD, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101512484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-6199 (Electronic) Linking ISSN: 17576180 NLM ISO Abbreviation: Bioanalysis Subsets: MEDLINE
Academic Journal
Fiedler-Kelly JB; Cognigen Corporation (a SimulationsPlus company), Buffalo, NY, USA.; Cohen-Barak O; Teva Pharmaceutical Industries Ltd., Netanya, Israel.; Morris DN; Gilead Sciences, Inc., Foster City, CA, USA.; Ludwig E; Cognigen Corporation (a SimulationsPlus company), Buffalo, NY, USA.; Rasamoelisolo M; Teva Pharmaceutical Industries Ltd., Frazer, PA, USA.; Shen H; Teva Pharmaceutical Industries Ltd., Frazer, PA, USA.; Levi M; Teva Pharmaceutical Industries Ltd., Frazer, PA, USA.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Academic Journal
Cherniakov I; Specialty Clinical Development, Teva Pharmaceutical Industries Ltd, Netanya, Israel.; Cohen-Barak O; Specialty Clinical Development, Teva Pharmaceutical Industries Ltd, Netanya, Israel.; Tiver R; Specialty Clinical Development Teva Branded Pharmaceutical Products R&D, West Chester, Pennsylvania, USA.; Gillespie M; Specialty Clinical Development Teva Branded Pharmaceutical Products R&D, West Chester, Pennsylvania, USA.; Kessler Y; Specialty Clinical Development, Teva Pharmaceutical Industries Ltd, Netanya, Israel.; Gutierrez M; Teva Internal Clinics US, Miramar, Florida, USA.; Rasamoelisolo M; Nonclinical Development Teva Pharmaceutical Industries Ltd, West Chester, Pennsylvania, USA.; Li S; Nonclinical Development Teva Pharmaceutical Industries Ltd, West Chester, Pennsylvania, USA.; Shen H; Nonclinical Development Teva Pharmaceutical Industries Ltd, West Chester, Pennsylvania, USA.; Hallak H; Specialty Clinical Development, Teva Pharmaceutical Industries Ltd, Netanya, Israel.; Loupe PS; Nonclinical Development Teva Pharmaceutical Industries Ltd, West Chester, Pennsylvania, USA.; Smith M; Device R&D, Teva Pharmaceutical Industries Ltd, Runcorn, United Kingdom.; Rabinovich-Guilatt L; Specialty Clinical Development, Teva Pharmaceutical Industries Ltd, Netanya, Israel.; Spiegelstein O; Specialty Clinical Development, Teva Pharmaceutical Industries Ltd, Netanya, Israel.
Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE
Academic Journal
Cohen-Barak O; 1 Global Research and Development, Teva Pharmaceuticals, Inc., Netanya, Israel.; Weiss S; 1 Global Research and Development, Teva Pharmaceuticals, Inc., Netanya, Israel.; Rasamoelisolo M; 1 Global Research and Development, Teva Pharmaceuticals, Inc., Netanya, Israel.; Faulhaber N; 1 Global Research and Development, Teva Pharmaceuticals, Inc., Netanya, Israel.; Yeung PP; 1 Global Research and Development, Teva Pharmaceuticals, Inc., Netanya, Israel.; Loupe PS; 1 Global Research and Development, Teva Pharmaceuticals, Inc., Netanya, Israel.; Yoon E; 2 PAREXEL International, Los Angeles, CA, USA.; Gandhi MD; 3 PRA Health Sciences, Lenexa, KS, USA.; Spiegelstein O; 1 Global Research and Development, Teva Pharmaceuticals, Inc., Netanya, Israel.; Aycardi E; 1 Global Research and Development, Teva Pharmaceuticals, Inc., Netanya, Israel.
Publisher: Sage Country of Publication: England NLM ID: 8200710 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2982 (Electronic) Linking ISSN: 03331024 NLM ISO Abbreviation: Cephalalgia Subsets: MEDLINE
Academic Journal
Cohen-Barak O; Teva Pharmaceuticals Inc.12 Hatrufa Street, Netanya 42504, IsraelTeva Biopharmaceuticals Inc.Rockville, Maryland, USATeva Pharmaceuticals Inc.Frazer, Pennsylvania, USACardiac Safety Consultants LtdLondon, UK orit.cohen-barak@teva.co.il.; Sakov A; Teva Pharmaceuticals Inc.12 Hatrufa Street, Netanya 42504, IsraelTeva Biopharmaceuticals Inc.Rockville, Maryland, USATeva Pharmaceuticals Inc.Frazer, Pennsylvania, USACardiac Safety Consultants LtdLondon, UK.; Rasamoelisolo M; Teva Pharmaceuticals Inc.12 Hatrufa Street, Netanya 42504, IsraelTeva Biopharmaceuticals Inc.Rockville, Maryland, USATeva Pharmaceuticals Inc.Frazer, Pennsylvania, USACardiac Safety Consultants LtdLondon, UK.; Bassan M; Teva Pharmaceuticals Inc.12 Hatrufa Street, Netanya 42504, IsraelTeva Biopharmaceuticals Inc.Rockville, Maryland, USATeva Pharmaceuticals Inc.Frazer, Pennsylvania, USACardiac Safety Consultants LtdLondon, UK.; Brown K; Teva Pharmaceuticals Inc.12 Hatrufa Street, Netanya 42504, IsraelTeva Biopharmaceuticals Inc.Rockville, Maryland, USATeva Pharmaceuticals Inc.Frazer, Pennsylvania, USACardiac Safety Consultants LtdLondon, UK.; Mendzelevski B; Teva Pharmaceuticals Inc.12 Hatrufa Street, Netanya 42504, IsraelTeva Biopharmaceuticals Inc.Rockville, Maryland, USATeva Pharmaceuticals Inc.Frazer, Pennsylvania, USACardiac Safety Consultants LtdLondon, UK.; Spiegelstein O; Teva Pharmaceuticals Inc.12 Hatrufa Street, Netanya 42504, IsraelTeva Biopharmaceuticals Inc.Rockville, Maryland, USATeva Pharmaceuticals Inc.Frazer, Pennsylvania, USACardiac Safety Consultants LtdLondon, UK.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9423848 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1479-683X (Electronic) Linking ISSN: 08044643 NLM ISO Abbreviation: Eur J Endocrinol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Rasamoelisolo, M.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어